• SyntekaBio shareholders approved amendments to the articles of incorporation expanding business purposes at an extraordinary meeting on October 16, 2026.
• Shareholders elected Park Seok-geun as an inside director and Cho Young-seok as a part-time auditor.
• The proposed election of Lee Dong-cheol as an independent director was withdrawn following his withdrawal as a candidate before the meeting.
• Shareholders authorized stock option grants.
• Separately, they ratified stock option grants previously awarded by the board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntekaBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016900678), on October 16, 2026, and is solely responsible for the information contained therein.